Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: case report and review of literature.
[allergic bronchopulmonary aspergillosis]
Objectives
:
To
review
the
data
available
in
literature
about
nebulized
amphotericin
B
(
AMB
)
in
the
treatment
of
allergic
bronchopulmonary
aspergillosis
(
ABPA
)
in
cystic
fibrosis
(
CF
)
and
to
report
our
experience
in
the
use
of
this
drug
,
with
a
particular
therapeutic
scheme
.
Case
Report
:
We
used
nebulized
liposomal
amphotericin
B
(
L-
AMB
)
in
a
patient
affected
by
CF
,
complicated
by
ABPA
.
The
previous
combined
treatment
with
oral
steroids
and
azoles
had
no
respiratory
benefit
and
caused
relevant
side
effects
.
Amphotericin
B
has
always
been
well
tolerated
and
permitted
a
slight
steroid
tapering
.
We
also
observed
benefits
in
pulmonary
function
and
laboratory
tests
.
Conclusions
:
Few
data
are
available
in
literature
about
the
use
of
nebulized
AMB
in
CF
and
there
are
no
RCTs
evaluating
antifungals
in
CF
-
ABPA
.
In
our
opinion
,
the
reported
case
suggests
that
nebulized
L-
AMB
could
represent
a
possible
strategy
in
ABPA
management
in
CF
patients
.
Diseases
Validation
Diseases presenting
"azoles had no respiratory benefit and caused relevant side effects"
symptom
allergic bronchopulmonary aspergillosis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom